DAG1 and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan: Dystroglycanopathies, which are caused by reduced glycosylation of alpha-dystroglycan, are a heterogeneous group of neurodegenerative disorders characterized by variable brain and skeletal muscle involvement.